BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $21,044,000 | +222.3% | 144,428 | +207.3% | 0.17% | +293.2% |
Q3 2021 | $6,529,000 | +43.1% | 47,005 | 0.0% | 0.04% | +41.9% |
Q2 2021 | $4,563,000 | +12.9% | 47,005 | -4.2% | 0.03% | -8.8% |
Q1 2021 | $4,040,000 | -3.9% | 49,067 | 0.0% | 0.03% | +3.0% |
Q4 2020 | $4,206,000 | -58.8% | 49,067 | -68.7% | 0.03% | -65.6% |
Q3 2020 | $10,199,000 | -19.3% | 156,887 | -9.2% | 0.10% | -27.8% |
Q2 2020 | $12,634,000 | +25.7% | 172,799 | -8.5% | 0.13% | +19.8% |
Q1 2020 | $10,047,000 | -2.2% | 188,799 | 0.0% | 0.11% | +0.9% |
Q4 2019 | $10,278,000 | -41.3% | 188,799 | -55.0% | 0.11% | -52.6% |
Q3 2019 | $17,514,000 | -12.3% | 419,799 | -8.3% | 0.23% | -6.8% |
Q2 2019 | $19,959,000 | -12.4% | 457,799 | +3.4% | 0.25% | -14.7% |
Q1 2019 | $22,792,000 | +12.5% | 442,799 | -19.2% | 0.29% | -6.1% |
Q4 2018 | $20,257,000 | +29.3% | 547,799 | +31.3% | 0.31% | +49.5% |
Q3 2018 | $15,670,000 | +91.4% | 417,299 | +101.5% | 0.21% | +60.0% |
Q2 2018 | $8,185,000 | +202.6% | 207,099 | +97.2% | 0.13% | +182.6% |
Q1 2018 | $2,705,000 | +25.3% | 105,000 | +31.2% | 0.05% | +24.3% |
Q4 2017 | $2,158,000 | – | 80,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |